Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Chloe Atreya, MD, PhD

Photo of Chloe Atreya, MD, PhD
Title(s)Professor, Medicine
SchoolSchool of Medicine
Address550 16th Street, #6556
San Francisco CA 94158
PronounsShe/Her/Hers
ORCID ORCID Icon0000-0003-2954-1727 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    Yale UniversityMD, PhD2005School of Medicine
    Princeton UniversityBA1998
    University of California, San Francisco, CA11/2019Diversity, Equity, and Inclusion Champion Training
    University of California, San Francisco, CA2019Diversity, Equity, and Inclusion Champion Training
    Collapse awards and honors
    2011American Cancer Society Postdoctoral Fellowship 11-183-01-TBG
    2011Conquer Cancer Foundation of the American Society of Clinical Oncology Young Investigator Award
    2012Alliance for Clinical Trials in Oncology Foundation Investigator Award
    2014The Ernest H. Rosenbaum MD Commitment to Patient Care Award, UCSF Symptom Management Service
    2017The Marcus Program in Precision Medicine Innovation Seeding Bold Ideas Award
    2017Clinical Innovation Center Inside Out Accelerator Award

    Collapse Overview 
    Collapse overview
    Dr. Chloe E. Atreya specializes in gastrointestinal cancer, particularly colorectal cancer, at the UCSF Helen Diller Comprehensive Cancer Center. She also co-directs the Integrative Onolcogy Program and Research Hub. Her research focuses on the interplay of tumor genetics and response to therapies for colorectal cancer, with the goal of improving patient outcomes and quality of life by personalizing treatment.
    Collapse Clinical Trials

    Collapse Research 
    Collapse research activities and funding
    Understanding Intrinsic Resistance to Direct KRAS Inhibition In colorectal Cancers
    NIH-NCI R37CA266549Jan 1, 2022 - Dec 21, 2026
    Role: Co-Investigator
    Optimization of a remote intervention to improve nutrition and physical activity in colorectal cancer survivors
    NIH/NCI R01CA248774Sep 1, 2020 - Aug 1, 2025
    Role: Co-Investigator
    Kinome-guided Targeting of Cooperative Dependencies in BRAF and KRAS Mutated Colorectal Cancer
    NIH R01CA229447Jun 1, 2019 - May 31, 2024
    Role: Principal Investigator
    (PQ10) Harnessing the human gut microbiome to predict chemotherapy outcomes
    NIH R21CA227232Jun 21, 2018 - May 31, 2021
    Role: Co-Principal Investigator
    Targeting of Aberrant Signaling in Patient-Derived Colorectal Cancer Models
    NIH K08CA175153Sep 15, 2013 - Apr 30, 2019
    Role: Principal Investigator

    Collapse Featured Content 
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. NCCN Guidelines® Insights: Distress Management, Version 1.2026. J Natl Compr Canc Netw. 2026 04; 24(4). Fann JR, Vanderlan J, Brewer BW, Corbett C, Keller J, Lahijani S, Niazi SK, Riba MB, Andersen B, Atreya CE, Braun I, Breitbart WS, Channa Y, Farabelli J, Fleishman S, Garcia S, Greenberg DB, Handzo RGF, Horyna A, Huang CH, Hutchinson S, Johns S, La Cava S, Leeper H, Martin S, Mukherjee D, Pailler M, Parnes F, Rao V, Rocha-Cadman X, Scher E, Schuster J, Thompson LMA, Usher A, Valentine AD, Montgomery S, Darlow S. PMID: 41956112.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Phase II Study of Pembrolizumab Plus Capecitabine and Bevacizumab for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer. Clin Colorectal Cancer. 2026 Feb 18. Bocobo A, Whitman J, Keenan BP, Koser KL, Kidder WA, Piawah S, Van Loon K, Behr SC, Kolli KP, Chen X, Onodera C, Pande M, Pollak M, Wang R, Babdor J, Spitzer MH, Zhang L, Fong L, Atreya CE. PMID: 41826077.
      View in: PubMed   Mentions:    Fields:    
    3. Shifts in the human gut microbiome during cancer chemotherapy are diet-dependent. bioRxiv. 2025 Dec 23. Trepka KR, Van Blarigan EL, Kyaw TS, Olson CA, Partipilo G, Ortega EF, Noecker C, Upadhyay V, Zhang C, Gempis D, Steiding P, Stanfield D, Venook AP, Atreya CE, Kidder WA, Turnbaugh PJ. PMID: 41497648; PMCID: PMC12767648.
      View in: PubMed   Mentions:
    4. Microbial vitamin biosynthesis links gut microbiota dynamics to chemotherapy toxicity. mBio. 2025 Jun 11; 16(6):e0093025. Hillege LE, Trepka KR, Guthrie BGH, Fu X, Aarnoutse R, Paymar MR, Olson C, Zhang C, Ortega E, Ramirez L, de Vos-Geelen J, Valkenburg-van Iersel L, van Hellemond IEG, Baars A, Vestjens JHMJ, Penders J, Deutschbauer A, Atreya CE, Kidder WA, Smidt ML, Ziemons J, Turnbaugh PJ. PMID: 40391895; PMCID: PMC12153289.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    5. Expansion of a bacterial operon during cancer treatment ameliorates fluoropyrimidine toxicity. Sci Transl Med. 2025 Apr 16; 17(794):eadq8870. Trepka KR, Kidder WA, Kyaw TS, Halsey T, Olson CA, Ortega EF, Noecker C, Upadhyay V, Stanfield D, Steiding P, Guthrie BGH, Spanogiannopoulos P, Dumlao D, Turnbaugh JA, Stachler MD, Van Blarigan EL, Venook AP, Atreya CE, Turnbaugh PJ. PMID: 40238917; PMCID: PMC12087798.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    6. Integrative Oncology: Incorporating Evidence-Based Approaches for Patients With GI Cancers. Am Soc Clin Oncol Educ Book. 2025 Jan; 45(1):e471734. Atreya CE, Leach H, Asiimwe E, Bahri N, Le BK, Macaire G, Wood KC, Van Blarigan EL, Lee RT. PMID: 39841946.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Expansion of a bacterial operon during cancer treatment ameliorates drug toxicity. bioRxiv. 2024 Oct 15. Trepka KR, Kidder WA, Kyaw TS, Halsey T, Olson CA, Ortega EF, Noecker C, Upadhyay V, Stanfield D, Steiding P, Guthrie BGH, Spanogiannopoulos P, Dumlao D, Turnbaugh JA, Stachler MD, Van Blarigan EL, Venook AP, Atreya CE, Turnbaugh PJ. PMID: 38895199; PMCID: PMC11185696.
      View in: PubMed   Mentions:
    8. Metagenomic analysis during capecitabine therapy reveals microbial chemoprotective mechanisms and predicts drug toxicity in colorectal cancer patients. medRxiv. 2024 Oct 15. Hillege LE, Trepka KR, Ziemons J, Aarnoutse R, Guthrie BGH, de Vos-Geelen J, Valkenburg-van Iersel L, van Hellemond IEG, Baars A, Vestjens JHMJ, Penders J, Deutschbauer A, Atreya CE, Kidder WA, Turnbaugh PJ, Smidt ML. PMID: 39484258; PMCID: PMC11527039.
      View in: PubMed   Mentions:
    9. Synchronous or metachronous breast and colorectal cancers in younger-than-average-age patients: a case series. Oncologist. 2024 Sep 06; 29(9):e1159-e1168. Silverstein J, Wright F, Stanfield D, Chien AJ, Wong JM, Park JW, Blanco A, Van Loon K, Atreya CE. PMID: 38856325; PMCID: PMC11379633.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. Association between gastrointestinal symptoms and specialty care utilization among colon cancer survivors: a cohort study. Int J Colorectal Dis. 2024 Aug 14; 39(1):130. Edwards AL, Trang K, Tolstykh IV, Van Blarigan EL, Van Loon K, Laffan A, Stanfield D, Steiding P, Neuhaus J, Atreya CE, Piawah S, Venook AP, Varma MG. PMID: 39138736; PMCID: PMC11322428.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment. Clin Cancer Res. 2024 Jul 15; 30(14):2964-2973. Parikh AR, Chee BH, Tsai J, Rich TA, Price KS, Patel SA, Zhang L, Ibrahim F, Esquivel M, Van Seventer EE, Jarnagin JX, Raymond VM, Corvera CU, Hirose K, Nakakura EK, Corcoran RB, Van Loon K, Atreya CE. PMID: 38695832; PMCID: PMC11247320.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    12. Mindfulness-Based Group Medical Visits: Strategies to Improve Equitable Access and Inclusion for Diverse Patients in Cancer Treatment. Glob Adv Integr Med Health. 2024 Jan-Dec; 13:27536130241263486. Mishra KK, Leung IC, Chao MT, Thompson-Lastad A, Pollak C, Dhruva A, Hartogensis W, Lister M, Cheng SW, Atreya CE. PMID: 38895040; PMCID: PMC11185011.
      View in: PubMed   Mentions: 3  
    13. Associations between the Gut Microbiota, Race, and Ethnicity of Patients with Colorectal Cancer: A Pilot and Feasibility Study. Cancers (Basel). 2023 Sep 13; 15(18). Piawah S, Kyaw TS, Trepka K, Stewart AL, Mora RV, Stanfield D, Levine K, Van Blarigan EL, Venook A, Turnbaugh PJ, Nguyen T, Atreya CE. PMID: 37760515; PMCID: PMC10526839.
      View in: PubMed   Mentions: 14  
    14. Integrative Oncology Care of Symptoms of Anxiety and Depression in Adults With Cancer: Society for Integrative Oncology-ASCO Guideline. J Clin Oncol. 2023 10 01; 41(28):4562-4591. Carlson LE, Ismaila N, Addington EL, Asher GN, Atreya C, Balneaves LG, Bradt J, Fuller-Shavel N, Goodman J, Hoffman CJ, Huston A, Mehta A, Paller CJ, Richardson K, Seely D, Siwik CJ, Temel JS, Rowland JH. PMID: 37582238.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    15. Variety of Fruit and Vegetables and Alcohol Intake are Associated with Gut Microbial Species and Gene Abundance in Colorectal Cancer Survivors. Am J Clin Nutr. 2023 09; 118(3):518-529. Kyaw TS, Upadhyay V, Tolstykh I, Van Loon K, Laffan A, Stanfield D, Gempis D, Kenfield SA, Chan JM, Piawah S, Atreya CE, Ng K, Venook A, Kidder W, Turnbaugh PJ, Van Blarigan EL. PMID: 37474105; PMCID: PMC10550847.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    16. Sexual function remains persistently low in women after treatment for colorectal cancer and anal squamous cell carcinoma. J Sex Med. 2023 03 31; 20(4):439-446. Savoie MB, Paciorek A, Van Loon K, Anwar M, Atreya CE, Johnson PC, Kenfield SA, Laffan A, Levin AO, Smith JF, Stanfield D, Venook A, Zhang L, Van Blarigan EL, Rowen T. PMID: 36805959; PMCID: PMC10078939.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    17. Quality of life among colorectal cancer survivors participating in a pilot randomized controlled trial of a web-based dietary intervention with text messages. Support Care Cancer. 2023 Feb 10; 31(3):155. Wang L, Langlais C, Kenfield SA, Van Loon K, Laffan A, Atreya CE, Chan JM, Zhang L, Allen IE, Miaskowski C, Fukuoka Y, Meyerhardt JA, Venook AP, Van Blarigan EL. PMID: 36763183; PMCID: PMC9918568.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    18. A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAFV600E colorectal tumors. Nat Cancer. 2023 02; 4(2):240-256. Ruiz-Saenz A, Atreya CE, Wang C, Pan B, Dreyer CA, Brunen D, Prahallad A, Muñoz DP, Ramms DJ, Burghi V, Spassov DS, Fewings E, Hwang YC, Cowdrey C, Moelders C, Schwarzer C, Wolf DM, Hann B, VandenBerg SR, Shokat K, Moasser MM, Bernards R, Gutkind JS, van 't Veer LJ, Coppé JP. PMID: 36759733; PMCID: PMC9970872.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    19. Phase I prospective trial of TAS-102 (trifluridine and tipiracil) and radioembolization with 90Y resin microspheres for chemo-refractory colorectal liver metastases. BMC Cancer. 2022 Dec 13; 22(1):1307. Fidelman N, Atreya CE, Griffith M, Milloy MA, Carnevale J, Cinar P, Venook AP, Van Loon K. PMID: 36514060; PMCID: PMC9749246.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    20. Optimizing intervention tools to improve nutrition and physical activity for colorectal cancer survivors (Tools To Be Fit): Study protocol of a randomized factorial experiment. Contemp Clin Trials. 2022 12; 123:107009. Kenfield SA, Philip EJ, Phillips SM, Meyerhardt JA, Chan JM, Atreya CE, Kim MO, Harris Q, Steiding P, Macaire G, McCullough ML, Piawah S, Johnson WY, Kurttila FA, Lewis WL, Pesmen C, Watson Y, Van Blarigan EL. PMID: 36396066; PMCID: PMC10561599.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    21. Association between adherence to the American Cancer Society Nutrition and Physical Activity Guidelines and stool frequency among colon cancer survivors: a cohort study. J Cancer Surviv. 2023 06; 17(3):836-847. Greenberg AL, Tolstykh IV, Van Loon K, Laffan A, Stanfield D, Steiding P, Kenfield SA, Chan JM, Atreya CE, Piawah S, Kidder W, Venook AP, Van Blarigan EL, Varma MG. PMID: 36335220; PMCID: PMC10209241.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    22. Host and gut bacteria share metabolic pathways for anti-cancer drug metabolism. Nat Microbiol. 2022 10; 7(10):1605-1620. Spanogiannopoulos P, Kyaw TS, Guthrie BGH, Bradley PH, Lee JV, Melamed J, Malig YNA, Lam KN, Gempis D, Sandy M, Kidder W, Van Blarigan EL, Atreya CE, Venook A, Gerona RR, Goga A, Pollard KS, Turnbaugh PJ. PMID: 36138165; PMCID: PMC9530025.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansAnimalsCells
    23. mHealth Interventions to Promote a Healthy Diet and Physical Activity among Cancer Survivors: A Systematic Review of Randomized Controlled Trials. Cancers (Basel). 2022 Aug 06; 14(15). Wang L, Langlais CS, Kenfield SA, Chan JM, Graff RE, Allen IE, Atreya CE, Van Blarigan EL. PMID: 35954479; PMCID: PMC9367623.
      View in: PubMed   Mentions: 22  
    24. The Gut Microbiome in Colorectal Cancer. Hematol Oncol Clin North Am. 2022 06; 36(3):491-506. Piawah S, Walker EJ, Van Blarigan EL, Atreya CE. PMID: 35577712.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    25. Quality of life of colorectal cancer survivors participating in a pilot randomized controlled trial of physical activity trackers and daily text messages. Support Care Cancer. 2022 May; 30(5):4557-4564. Chan H, Van Loon K, Kenfield SA, Chan JM, Mitchell E, Zhang L, Paciorek A, Joseph G, Laffan A, Atreya C, Fukuoka Y, Miaskowski C, Meyerhardt JA, Venook AP, Van Blarigan EL. PMID: 35119520; PMCID: PMC8942969.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    26. Feasibility and Acceptability of a Physical Activity Tracker and Text Messages to Promote Physical Activity During Chemotherapy for Colorectal Cancer: Pilot Randomized Controlled Trial (Smart Pace II). JMIR Cancer. 2022 Jan 11; 8(1):e31576. Van Blarigan EL, Dhruva A, Atreya CE, Kenfield SA, Chan JM, Milloy A, Kim I, Steiding P, Laffan A, Zhang L, Piawah S, Fukuoka Y, Miaskowski C, Hecht FM, Kim MO, Venook AP, Van Loon K. PMID: 35014958; PMCID: PMC8790683.
      View in: PubMed   Mentions: 11     Fields:    
    27. Characteristics and Growth Rate of Lung Metastases in Patients With Primary Gastrointestinal Malignancies and Lung-dominant Metastatic Disease: A Retrospective Cohort Analysis. Am J Clin Oncol. 2022 01 01; 45(1):22-27. Burns S, Vella M, Paciorek A, Zhang L, Atreya CE, Feng M, Kelley RK, Tempero MA, Van Loon K, Ko AH. PMID: 34864778.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    28. Discovering dominant tumor immune archetypes in a pan-cancer census. Cell. 2022 01 06; 185(1):184-203.e19. Combes AJ, Samad B, Tsui J, Chew NW, Yan P, Reeder GC, Kushnoor D, Shen A, Davidson B, Barczak AJ, Adkisson M, Edwards A, Naser M, Barry KC, Courau T, Hammoudi T, Argüello RJ, Rao AA, Olshen AB, Immunoprofiler Consortium, Cai C, Zhan J, Davis KC, Kelley RK, Chapman JS, Atreya CE, Patel A, Daud AI, Ha P, Diaz AA, Kratz JR, Collisson EA, Fragiadakis GK, Erle DJ, Boissonnas A, Asthana S, Chan V, Krummel MF. PMID: 34963056; PMCID: PMC8862608.
      View in: PubMed   Mentions: 85     Fields:    Translation:HumansCells
    29. Being Present 2.0: Online Mindfulness-Based Program for Metastatic Gastrointestinal Cancer Patients and Caregivers. Glob Adv Health Med. 2021; 10:21649561211044693. Dragomanovich HM, Dhruva A, Ekman E, Schoenbeck KL, Kubo A, Van Blarigan EL, Borno HT, Esquivel M, Chee B, Campanella M, Philip EJ, Rettger JP, Rosenthal B, Van Loon K, Venook AP, Boscardin C, Moran P, Hecht FM, Atreya CE. PMID: 35174001; PMCID: PMC8842457.
      View in: PubMed   Mentions: 9  
    30. Molecular and Radiological Features of Microsatellite Stable Colorectal Cancer Cases With Dramatic Responses to Immunotherapy. Anticancer Res. 2021 Jun; 41(6):2985-2992. Keenan BP, VAN Loon K, Khilnani AD, Fidelman N, Behr SC, Atreya CE, Oh DY. PMID: 34083289; PMCID: PMC8631311.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    31. Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406). J Clin Oncol. 2021 02 01; 39(4):285-294. Kopetz S, Guthrie KA, Morris VK, Lenz HJ, Magliocco AM, Maru D, Yan Y, Lanman R, Manyam G, Hong DS, Sorokin A, Atreya CE, Diaz LA, Allegra C, Raghav KP, Wang SE, Lieu CH, McDonough SL, Philip PA, Hochster HS. PMID: 33356422; PMCID: PMC8462593.
      View in: PubMed   Mentions: 215     Fields:    Translation:HumansCTClinical Trials
    32. Molecular Insights in Transmission of Cancer From an Organ Donor to Four Transplant Recipients. J Natl Compr Canc Netw. 2020 11; 18(11):1446-1452. Atreya CE, Collisson EA, Park M, Grenert JP, Behr SC, Gonzalez A, Chou J, Maisel S, Friedlander TW, Freise CE, Shoji J, Semrad TJ, Van Ziffle J, Chin-Hong P. PMID: 33152701.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    33. Association of Diet Quality With Survival Among People With Metastatic Colorectal Cancer in the Cancer and Leukemia B and Southwest Oncology Group 80405 Trial. JAMA Netw Open. 2020 10 01; 3(10):e2023500. Van Blarigan EL, Zhang S, Ou FS, Venlo A, Ng K, Atreya C, Van Loon K, Niedzwiecki D, Giovannucci E, Wolfe EG, Lenz HJ, Innocenti F, O'Neil BH, Shaw JE, Polite BN, Hochster HS, Atkins JN, Goldberg RM, Mayer RJ, Blanke CD, O'Reilly EM, Fuchs CS, Meyerhardt JA. PMID: 33125497; PMCID: PMC7599454.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    34. ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper. Nat Rev Clin Oncol. 2020 12; 17(12):757-770. Dasari A, Morris VK, Allegra CJ, Atreya C, Benson AB, Boland P, Chung K, Copur MS, Corcoran RB, Deming DA, Dwyer A, Diehn M, Eng C, George TJ, Gollub MJ, Goodwin RA, Hamilton SR, Hechtman JF, Hochster H, Hong TS, Innocenti F, Iqbal A, Jacobs SA, Kennecke HF, Lee JJ, Lieu CH, Lenz HJ, Lindwasser OW, Montagut C, Odisio B, Ou FS, Porter L, Raghav K, Schrag D, Scott AJ, Shi Q, Strickler JH, Venook A, Yaeger R, Yothers G, You YN, Zell JA, Kopetz S. PMID: 32632268; PMCID: PMC7790747.
      View in: PubMed   Mentions: 199     Fields:    Translation:Humans
    35. Factors Impacting Differential Outcomes in the Definitive Radiation Treatment of Anal Cancer Between HIV-Positive and HIV-Negative Patients. Oncologist. 2020 09; 25(9):772-779. Susko M, Wang CJ, Lazar AA, Kim S, Laffan A, Feng M, Ko A, Venook AP, Atreya CE, Van Loon K, Anwar M. PMID: 32390297; PMCID: PMC7485368.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    36. Probing the tumor micro(b)environment. Science. 2020 05 29; 368(6494):938-939. Atreya CE, Turnbaugh PJ. PMID: 32467376.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    37. Embedded palliative care for patients with metastatic colorectal cancer: a mixed-methods pilot study. Support Care Cancer. 2020 Dec; 28(12):5995-6010. Bischoff KE, Zapata C, Sedki S, Ursem C, O'Riordan DL, England AE, Thompson N, Alfaro A, Rabow MW, Atreya CE. PMID: 32285263.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    38. BRAF-Mutant Transcriptional Subtypes Predict Outcome of Combined BRAF, MEK, and EGFR Blockade with Dabrafenib, Trametinib, and Panitumumab in Patients with Colorectal Cancer. Clin Cancer Res. 2020 06 01; 26(11):2466-2476. Middleton G, Yang Y, Campbell CD, André T, Atreya CE, Schellens JHM, Yoshino T, Bendell JC, Hollebecque A, McRee AJ, Siena S, Gordon MS, Tabernero J, Yaeger R, O'Dwyer PJ, De Vos F, Van Cutsem E, Millholland JM, Brase JC, Rangwala F, Gasal E, Corcoran RB. PMID: 32047001; PMCID: PMC8194012.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    39. Clinicopathologic Characteristics and Impact of Oophorectomy for Ovarian Metastases from Colorectal Cancer. Oncologist. 2020 07; 25(7):564-571. Ursem C, Zhou M, Paciorek A, Atreya CE, Ko AH, Venook A, Zhang L, Van Loon K. PMID: 32031306; PMCID: PMC7356671.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    40. Postoperative Exacerbation of Oxaliplatin-induced Neurotoxicity in Gastrointestinal Cancers: A Case Series. Anticancer Res. 2020 02; 40(2):865-871. Gonzalez A, Walker EJ, Van Loon K, Cinar P, Atreya CE. PMID: 32014930.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    41. Feasibility and Acceptability of a Web-Based Dietary Intervention with Text Messages for Colorectal Cancer: A Randomized Pilot Trial. Cancer Epidemiol Biomarkers Prev. 2020 04; 29(4):752-760. Van Blarigan EL, Kenfield SA, Chan JM, Van Loon K, Paciorek A, Zhang L, Chan H, Savoie MB, Bocobo AG, Liu VN, Wong LX, Laffan A, Atreya CE, Miaskowski C, Fukuoka Y, Meyerhardt JA, Venook AP. PMID: 31941707; PMCID: PMC7125029.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    42. Vitamin D Levels in Patients with Colorectal Cancer Before and After Treatment Initiation. J Gastrointest Cancer. 2019 Dec; 50(4):769-779. Savoie MB, Paciorek A, Zhang L, Van Blarigan EL, Sommovilla N, Abrams D, Atreya CE, Bergsland EK, Chern H, Kelley RK, Ko A, Laffan A, Sarin A, Varma MG, Venook AP, Van Loon K. PMID: 30058032; PMCID: PMC6650370.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    43. Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164. J Clin Oncol. 2020 01 01; 38(1):11-19. Le DT, Kim TW, Van Cutsem E, Geva R, Jäger D, Hara H, Burge M, O'Neil B, Kavan P, Yoshino T, Guimbaud R, Taniguchi H, Elez E, Al-Batran SE, Boland PM, Crocenzi T, Atreya CE, Cui Y, Dai T, Marinello P, Diaz LA, André T. PMID: 31725351; PMCID: PMC7031958.
      View in: PubMed   Mentions: 517     Fields:    Translation:HumansCellsCTClinical Trials
    44. A multi-modal data resource for investigating topographic heterogeneity in patient-derived xenograft tumors. Sci Data. 2019 10 31; 6(1):253. Rajaram S, Roth MA, Malato J, VandenBerg S, Hann B, Atreya CE, Altschuler SJ, Wu LF. PMID: 31672976; PMCID: PMC6823477.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    45. Hormone receptor expression of colorectal cancer diagnosed during the peri-partum period. Endocr Connect. 2019 Aug; 8(8):1149-1158. Silverstein J, Kidder W, Fisher S, Hope TA, Maisel S, Ng D, Van Ziffle J, Atreya CE, Van Loon K. PMID: 31370007; PMCID: PMC6686950.
      View in: PubMed   Mentions: 3  
    46. Improving Access to Integrative Oncology Through Group Medical Visits: A Pilot Implementation Project. J Altern Complement Med. 2019 Jul; 25(7):733-739. Thompson-Lastad A, Atreya CE, Chao MT, Pollak C, Dhruva A, Santana T, Abrams DI. PMID: 31314561; PMCID: PMC6648219.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    47. Self-monitoring and reminder text messages to increase physical activity in colorectal cancer survivors (Smart Pace): a pilot randomized controlled trial. BMC Cancer. 2019 Mar 11; 19(1):218. Van Blarigan EL, Chan H, Van Loon K, Kenfield SA, Chan JM, Mitchell E, Zhang L, Paciorek A, Joseph G, Laffan A, Atreya CE, Fukuoka Y, Miaskowski C, Meyerhardt JA, Venook AP. PMID: 30866859; PMCID: PMC6417122.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    48. Of Microbes and Microsatellites. Cancer Immunol Res. 2018 11; 6(11):1290-1291. Atreya CE, Venook AP. PMID: 30389718.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    49. Applying New Models of Care to Meet Patient Needs in Integrative Oncology. J Altern Complement Med. 2018 Sep/Oct; 24(9-10):1010-1011. Dhruva A, Atreya CE, Chao MT. PMID: 30247958; PMCID: PMC6909738.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    50. Being Present: A single-arm feasibility study of audio-based mindfulness meditation for colorectal cancer patients and caregivers. PLoS One. 2018; 13(7):e0199423. Atreya CE, Kubo A, Borno HT, Rosenthal B, Campanella M, Rettger JP, Joseph G, Allen IE, Venook AP, Altschuler A, Dhruva A. PMID: 30036361; PMCID: PMC6056029.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    51. Emerging treatment options for BRAF-mutant colorectal cancer. Gastrointest Cancer. 2018; 8:13-23. Ursem C, Atreya CE, Van Loon K. PMID: 29628780; PMCID: PMC5889076.
      View in: PubMed   Mentions: 30  
    52. Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAFV600E-Mutant Colorectal Cancer. Cancer Discov. 2018 04; 8(4):428-443. Corcoran RB, André T, Atreya CE, Schellens JHM, Yoshino T, Bendell JC, Hollebecque A, McRee AJ, Siena S, Middleton G, Muro K, Gordon MS, Tabernero J, Yaeger R, O'Dwyer PJ, Humblet Y, De Vos F, Jung AS, Brase JC, Jaeger S, Bettinger S, Mookerjee B, Rangwala F, Van Cutsem E. PMID: 29431699; PMCID: PMC5882509.
      View in: PubMed   Mentions: 323     Fields:    Translation:HumansCellsCTClinical Trials
    53. Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer. Cancer Discov. 2018 02; 8(2):164-173. Strickler JH, Loree JM, Ahronian LG, Parikh AR, Niedzwiecki D, Pereira AAL, McKinney M, Korn WM, Atreya CE, Banks KC, Nagy RJ, Meric-Bernstam F, Lanman RB, Talasaz A, Tsigelny IF, Corcoran RB, Kopetz S. PMID: 29196463; PMCID: PMC5809260.
      View in: PubMed   Mentions: 159     Fields:    Translation:Humans
    54. Sampling strategies to capture single-cell heterogeneity. Nat Methods. 2017 Oct; 14(10):967-970. Rajaram S, Heinrich LE, Gordan JD, Avva J, Bonness KM, Witkiewicz AK, Malter JS, Atreya CE, Warren RS, Wu LF, Altschuler SJ. PMID: 28869755; PMCID: PMC5658002.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    55. Prolonged Response to HER2-Directed Therapy in a Patient With HER2-Amplified, Rapidly Progressive Metastatic Colorectal Cancer. J Natl Compr Canc Netw. 2017 01; 15(1):3-8. Parikh A, Atreya C, Korn WM, Venook AP. PMID: 28040715; PMCID: PMC5564419.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    56. Systemic Therapy for Metastatic Colorectal Cancer: From Current Standards to Future Molecular Targeted Approaches. Am Soc Clin Oncol Educ Book. 2017; 37:246-256. Atreya CE, Yaeger R, Chu E. PMID: 28561718.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    57. Radioembolization with 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study. J Gastrointest Oncol. 2016 Dec; 7(6):860-874. Fidelman N, Kerlan RK, Hawkins RA, Pampaloni M, Taylor AG, Kohi MP, Kolli KP, Atreya CE, Bergsland EK, Kelley RK, Ko AH, Korn WM, Van Loon K, McWhirter RM, Luan J, Johanson C, Venook AP. PMID: 28078110; PMCID: PMC5177572.
      View in: PubMed   Mentions: 14  
    58. Role of Biologics in Colon Cancer: Still Not Clear. J Oncol Pract. 2016 12; 12(12):1229-1230. Atreya CE, Venook AP. PMID: 27943687; PMCID: PMC5455590.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    59. Differential Radiographic Appearance of BRAF V600E-Mutant Metastatic Colorectal Cancer in Patients Matched by Primary Tumor Location. J Natl Compr Canc Netw. 2016 12; 14(12):1536-1543. Atreya CE, Greene C, McWhirter RM, Ikram NS, Allen IE, Van Loon K, Venook AP, Yeh BM, Behr SC. PMID: 27956538; PMCID: PMC5551390.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    60. A phase II study of axitinib in advanced neuroendocrine tumors. Endocr Relat Cancer. 2016 05; 23(5):411-8. Strosberg JR, Cives M, Hwang J, Weber T, Nickerson M, Atreya CE, Venook A, Kelley RK, Valone T, Morse B, Coppola D, Bergsland EK. PMID: 27080472; PMCID: PMC4963225.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    61. Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer. J Clin Oncol. 2015 Dec 01; 33(34):4023-31. Corcoran RB, Atreya CE, Falchook GS, Kwak EL, Ryan DP, Bendell JC, Hamid O, Messersmith WA, Daud A, Kurzrock R, Pierobon M, Sun P, Cunningham E, Little S, Orford K, Motwani M, Bai Y, Patel K, Venook AP, Kopetz S. PMID: 26392102; PMCID: PMC4669588.
      View in: PubMed   Mentions: 271     Fields:    Translation:HumansAnimalsCTClinical Trials
    62. Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas. Cancer Discov. 2015 Oct; 5(10):1040-8. Zill OA, Greene C, Sebisanovic D, Siew LM, Leng J, Vu M, Hendifar AE, Wang Z, Atreya CE, Kelley RK, Van Loon K, Ko AH, Tempero MA, Bivona TG, Munster PN, Talasaz A, Collisson EA. PMID: 26109333; PMCID: PMC4592417.
      View in: PubMed   Mentions: 157     Fields:    Translation:Humans
    63. Expanded RAS: refining the patient population. J Clin Oncol. 2015 Mar 01; 33(7):682-5. Atreya CE, Corcoran RB, Kopetz S. PMID: 25584005; PMCID: PMC4334773.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    64. Potent antitumor activity of cabozantinib, a c-MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model. Int J Cancer. 2015 Apr 15; 136(8):1967-75. Song EK, Tai WM, Messersmith WA, Bagby S, Purkey A, Quackenbush KS, Pitts TM, Wang G, Blatchford P, Yahn R, Kaplan J, Tan AC, Atreya CE, Eckhardt G, Kelley RK, Venook A, Kwak EL, Ryan D, Arcaroli JJ. PMID: 25242168; PMCID: PMC4323738.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    65. Association of TP53 mutational status and gender with survival after adjuvant treatment for stage III colon cancer: results of CALGB 89803. Clin Cancer Res. 2013 Oct 15; 19(20):5777-87. Warren RS, Atreya CE, Niedzwiecki D, Weinberg VK, Donner DB, Mayer RJ, Goldberg RM, Compton CC, Zuraek MB, Ye C, Saltz LB, Bertagnolli MM. PMID: 23983256; PMCID: PMC4122229.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    66. PTEN expression is consistent in colorectal cancer primaries and metastases and associates with patient survival. Cancer Med. 2013 Aug; 2(4):496-506. Atreya CE, Sangale Z, Xu N, Matli MR, Tikishvili E, Welbourn W, Stone S, Shokat KM, Warren RS. PMID: 24156022; PMCID: PMC3799284.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    67. Cancer Medicine. PTEN Expression is Consistent in Colorectal Cancer Primaries and Metastases and Associates with Patient Survival. 2013. Atreya CE, Sangale Z, Xu N, Matli MR, Tikishvili E, Welbourn W, Stone S, Shokat KM, and Warren RS. View Publication.
    68. Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors. Oncogene. 2014 Mar 20; 33(12):1590-600. Ducker GS, Atreya CE, Simko JP, Hom YK, Matli MR, Benes CH, Hann B, Nakakura EK, Bergsland EK, Donner DB, Settleman J, Shokat KM, Warren RS. PMID: 23542178; PMCID: PMC3982880.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansAnimalsCells
    69. Personalized Medicine in Oncology. KRAS and Colorectal Cancer: Shades of Gray. 2012; 6(1). Atreya CE, Ostrem JM, and Kelley RK.
    70. Predictive biomarkers in advance of a companion drug: ahead of their time? J Natl Compr Canc Netw. 2012 Mar; 10(3):303-9. Kelley RK, Atreya C, Venook AP, Febbo PG. PMID: 22393192.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    71. Combination of ATP-competitive mammalian target of rapamycin inhibitors with standard chemotherapy for colorectal cancer. Invest New Drugs. 2012 Dec; 30(6):2219-25. Atreya CE, Ducker GS, Feldman ME, Bergsland EK, Warren RS, Shokat KM. PMID: 22270257.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    Chloe's Networks
    Concepts (271)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (118)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-22-g09c84f92 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.